Shineco Inc., a NASDAQ-listed manufacturer specializing in induced pluripotent stem cell technology, has announced the creation of a new Biological Cell Digital Business Division. This strategic move aims to integrate its biological cell assets with blockchain technology to enhance global distribution and sales. Appointed as General Manager, Mr. Lin Hongguang, formerly of the Korea Digital Currency Research Institute, will lead the division's efforts to build a blockchain-based ecosystem within the biological cell sector. The initiative seeks to address industry challenges by enabling cross-regional collaboration and improving access to cell technology services. The company sees this development as a pivotal element of its growth strategy, poised to increase global market share and shareholder value.